Accès gratuit
Numéro
Med Sci (Paris)
Volume 30, Numéro 10, Octobre 2014
Page(s) 874 - 881
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20143010014
Publié en ligne 14 octobre 2014
  1. Caligiuri G. Rôle de l’immunité dans l’athérosclérose et dans les syndromes coronariens aigus. Med Sci (Paris) 2004 ; 20 : 175–181. [CrossRef] [EDP Sciences] [PubMed]
  2. Anderson GF, Chu E. Expanding priorities. Confronting chronic disease in countries with low income. N Engl J Med 2007 ; 356 : 209–211. [CrossRef] [PubMed]
  3. Emmerich J. L’athérosclérose. Collection Pathologie Science, Paris : John Libbey Eurotext, 2000.
  4. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000 ; 28 : 1815–1826. [CrossRef] [PubMed]
  5. Campbell KA, Lipinski MJ, Doran AC, et al. Lymphocytes and the adventitial immune response in atherosclerosis. Circ Res 2012 ; 110 : 889–900. [CrossRef] [PubMed]
  6. Hamze M, Desmetz C, Guglielmi P. B cell-derived cytokines in disease. Eur Cytokine Netw 2013 ; 24 : 20–26. [PubMed]
  7. De Jager SCA, Kuiper J. Vaccination strategies in atherosclerosis. Thromb Haemost 2011 ; 106 : 796–803. [CrossRef] [PubMed]
  8. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002 ; 109 : 745–753. [CrossRef] [PubMed]
  9. Major AS, Fazio S, Linton MF. B-Lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002 ; 22 : 1892–1898. [CrossRef] [PubMed]
  10. Ait-Oufella H, Herbin O, Bouaziz JD, et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010 ; 207 : 1579–1587. [CrossRef] [PubMed]
  11. Kyaw T, Tay C, Khan A, et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010 ; 185 : 4410–4419. [CrossRef] [PubMed]
  12. Ponnuswamy P, Van Vre EA, Mallat Z, Tedgui A. Humoral and cellular immune responses in atherosclerosis: spotlight on B- and T-cells. Vascul Pharmacol 2012 ; 56 : 193–203. [CrossRef] [PubMed]
  13. Mironova M, Virella G, Lopes-Virella MF. Isolation and characterization of human antioxidized LDL autoantibodies. Arterioscler Thromb Vasc Biol 1996 ; 16 : 222–229. [CrossRef] [PubMed]
  14. Kyaw T, Tipping P, Toh BH, Bobik A. Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis. Curr Opin Lipidol 2011 ; 22 : 373–379. [CrossRef] [PubMed]
  15. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006 ; 6 : 205–217. [CrossRef] [PubMed]
  16. Lusis AJ. Atherosclerosis. Nature 2000 ; 407 : 233–241. [CrossRef] [PubMed]
  17. Doran AC, Lipinski MJ, Oldham SN, et al. B-cell aortic homing and atheroprotection depend on Id3. Circ Res 2012 ; 110 : e1–e12. [CrossRef] [PubMed]
  18. Hamze M, Desmetz C, Berthe ML, et al. Characterization of resident B cells of vascular walls in human atherosclerotic patients. J Immunol 2013 ; 191 : 3006–3016. [CrossRef] [PubMed]
  19. Burioni R, Canducci F, Saita D, et al. Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques. J Immunol 2009 ; 183 : 2537–2544. [CrossRef] [PubMed]
  20. Kyaw T, Tipping P, Bobik A, Toh BH. Protective role of natural IgM-producing B1a cells in atherosclerosis. Trends Cardiovasc Med 2012 ; 22 : 48–53. [CrossRef] [PubMed]
  21. Lewis MJ, Malik TH, Ehrenstein MR, et al. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient lice. Circulation 2009 ; 120 : 417–426. [CrossRef] [PubMed]
  22. Perry HM, Bender TP, McNamara CA. B cell subsets in atherosclerosis. Front Immunol 2012 ; 3 : 373. [CrossRef] [PubMed]
  23. Allan LL, Hoefl K, Zheng DJ, et al. Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells. Blood 2009 ; 114 : 2411–2416. [CrossRef] [PubMed]
  24. Palinski W, Tangirala RK, Miller E, et al. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol 1995 ; 15 : 1569–1576. [CrossRef] [PubMed]
  25. Klimov AN, Denisenko AD, Vinogradov AG, et al. Accumulation of cholesteryl esters in macrophages incubated with human lipoprotein-antibody autoimmune complex. Atherosclerosis 1988 ; 74 : 41–46. [CrossRef] [PubMed]
  26. Nicoletti A, Paulsson G, Caligiuri G, et al. Induction of neonatal tolerance to oxidized lipoprotein reduces atherosclerosis tn ApoE knockout mice. Mol Med 2000 ; 6 : 283–290. [PubMed]
  27. Zhou XH, Caligiuri G, Hamsten A, et al. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001 ; 21 : 108–114. [CrossRef] [PubMed]
  28. Hernandez-Vargas P, Ortiz-Munoz G, Lopez-Franco O, et al. Fc gamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. Circ Res 2006 ; 99 : 1188–1196. [CrossRef] [PubMed]
  29. Mendez-Fernandez YV, Stevenson BG, Diehl CJ, et al. The inhibitory Fc gamma RIIb modulates the inflammatory response and influences atherosclerosis in male apoE-/- mice. Atherosclerosis 2011 ; 214 : 73–80. [CrossRef] [PubMed]
  30. Galkina E, Kadl A, Sanders J, et al. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 2006 ; 203 : 1273–1282. [CrossRef] [PubMed]
  31. Varthaman A, Khallou-Laschet J, Thaunat O, et al. L’athérogenèse : une maladie dysimmunitaire. Med Sci (Paris) 2008 ; 24 : 169–176. [CrossRef] [EDP Sciences] [PubMed]
  32. Bouaziz JD, de Masson A, Le Buanec H, et al. Lymphocytes B régulateurs : état des connaissances. Med Sci (Paris) 2014 ; 30 : 721–724. [CrossRef] [EDP Sciences] [PubMed]
  33. Catalan N, Imai K, Revy P, et al. Deux ans après, l’activation induced cytidine deaminase n’a pas livré tous ses secrets. Med Sci (Paris) 2003 ; 19 : 139–141. [CrossRef] [EDP Sciences] [PubMed]
  34. Cartron G, Rossi JF. Anticorps monoclonaux thérapeutiques en oncohématologie. Med Sci (Paris) 2009 ; 25 : 1085–1089. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.